Correlation Between Faron Pharmaceuticals and Eastinco Mining

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Faron Pharmaceuticals and Eastinco Mining at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Faron Pharmaceuticals and Eastinco Mining into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Faron Pharmaceuticals Oy and Eastinco Mining Exploration, you can compare the effects of market volatilities on Faron Pharmaceuticals and Eastinco Mining and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Faron Pharmaceuticals with a short position of Eastinco Mining. Check out your portfolio center. Please also check ongoing floating volatility patterns of Faron Pharmaceuticals and Eastinco Mining.

Diversification Opportunities for Faron Pharmaceuticals and Eastinco Mining

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Faron and Eastinco is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Faron Pharmaceuticals Oy and Eastinco Mining Exploration in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eastinco Mining Expl and Faron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Faron Pharmaceuticals Oy are associated (or correlated) with Eastinco Mining. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eastinco Mining Expl has no effect on the direction of Faron Pharmaceuticals i.e., Faron Pharmaceuticals and Eastinco Mining go up and down completely randomly.

Pair Corralation between Faron Pharmaceuticals and Eastinco Mining

Assuming the 90 days trading horizon Faron Pharmaceuticals Oy is expected to under-perform the Eastinco Mining. But the stock apears to be less risky and, when comparing its historical volatility, Faron Pharmaceuticals Oy is 1.31 times less risky than Eastinco Mining. The stock trades about -0.23 of its potential returns per unit of risk. The Eastinco Mining Exploration is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest  4,650  in Eastinco Mining Exploration on October 30, 2024 and sell it today you would earn a total of  750.00  from holding Eastinco Mining Exploration or generate 16.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Faron Pharmaceuticals Oy  vs.  Eastinco Mining Exploration

 Performance 
       Timeline  
Faron Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Faron Pharmaceuticals Oy are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Faron Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Eastinco Mining Expl 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Eastinco Mining Exploration are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Eastinco Mining may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Faron Pharmaceuticals and Eastinco Mining Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Faron Pharmaceuticals and Eastinco Mining

The main advantage of trading using opposite Faron Pharmaceuticals and Eastinco Mining positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Faron Pharmaceuticals position performs unexpectedly, Eastinco Mining can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eastinco Mining will offset losses from the drop in Eastinco Mining's long position.
The idea behind Faron Pharmaceuticals Oy and Eastinco Mining Exploration pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance